C&O Pharm   

C&O Pharmaceutical

heavy seller at 50cnts..very much on new management team..they should publish the new path of the company to convince the investors..

 

maybe starting of a rally.

load up before you are left out.

 

dont worry. when indicators points to a rally, then punters and investors will start take positions. usually they will wait for indications, some prefer to accumulate and wait for rally, they may benefit most and gain most from the rally during this stage.

no doubt about this counter. investors are not very familiar with japanese companies like this. if it is a eurporean company, this gem is close to 60 cents already. give it some time, it will be there anyway.

load up before you are left out.

 

buy lah..with the giant behind..thing will getting better..why not much people interest when sumi join in the company?heeeeeeeeee

 

do collect when its less than 50 cents. huge rally wave awaiting.

load up before you are left out.

 

collect now. this stock will rally up hard when next few annoucements relating to sumitomo products.

load up before you are left out.

 

Cool bro! I have just queued another 10 lots.... collect more

 

from cimb

 

Fundamentally…
C&O Pharmaceutical (COPT SP; S$0.495, Buy) – We like C&O pharmaceutical for its strong turnaround from industry downturn and international expansion potential. Share price catalysts include the strong products growth and expansion being the key distributor in China by international pharmaceutical names. The possibility of strategic investor, Sumitomo increasing its current stake could also potentially trigger privatisation in the horizon. Maintain BUY and a TP of S$0.66.

 

 

/i come i read i post/

 

 

load up before you are left out

 

im very interested in the stocks that fundamentally are very sound. but they are usually very slow in uptrend as people dont speculate them. c&o is a very very good stock for investors to gain exposure into the pharma markets in china. think i have mentioned this as early as oct that there are talks and discussions with foreign partners. initially i thought there are eurporean pharma names but its japanese name. the initial buy ups from the investors to push the stock px to 0.505 and later pulled back to 0.49 tells a lot that they are not excited about this. but i would think for mid term to even long term it is very exciting. if you studied the kind of medicines they produced and the licenses they have in china, you will be excited. i believe they have talked to others as well but only sumitomo offers stakes in this depth.

refer to the recent philip securities buy call on this. they have increased stakes to 29%, only a percent away from making a mandatory take over of the company. there are some strategic changes to the board as well. it looks pretty exciting to me. there are plans and there are good ones ahead. the pharma markets is sunrise industry and it is ever growing to endless demands. its current valuations is very attractive as compared to its peers.   

 

Bro, I admire yr love for C&O. 

I support you to collect more!!! 

 

may stay around range of 0.49 to 0.505 for time being. rsi is curving unfavourably but stochastic is bending in favour.

but fundamentals of stock remains strong. do collect in this pharse.

 

 

huge potential for this gem for the kind of distribution networks it has in china. the tie up with this japanese giant will further push up the company into next higher platform. current valuation is very attractive if you want a piece of pharma sector into china plays.

personally would think it is a 2x baggers in months to come when it started lauched the new products.

load up before you are left out.

 

C&O Pharmaceutical Technology (Holdings) Limited on Wednesday announced that Sumitomo Corporation, has entered into a sale and purchase agreement with Leo Star Development Limited, an investment holding company helmed by C&O's Executive Chairman Mr Gao Bin, for a 29 per cent stake in C&O for $96.19 million (US$72.84 million) or $0.50 per share. On completion of the acquisition, Leo Star and Mr Gao together will own about 29.17 per cent in C&O while Sumitomo will be the group's second largest substantial shareholder with 29 per cent interest. Sumitomo will nominate three executive directors to sit on C&O's Board, who will replace three existing directors of C&O, and one of whom will be designated as Chairman of the Board while Mr Gao will be redesignated as the Group's Vice Chairman

 

 Source: SGX Masnet

 

C&O Pharmaceutical Technology up on stake sale to Sumitomo

WRITTEN BY THOMSON REUTERS

WEDNESDAY, 01 DECEMBER 2010 10:41

Shares of Singapore-listed C&O Pharmaceutical Technology (COPT.SI) rose as much as 4.1% on Wednesday after it said Sumitomo Corporation (8053.T) had bought 29% of its issued shares for $96.2 million or $0.50 per share. At 0233 GMT, C&O shares were up 2.1% at $0.495 on a volume of 5.5 million shares.   China-based C&O earlier told the stock exchange that controlling shareholder Gao Bin and his holding company had sold the 29% stake to Sumitomo.   Reyoung Pharmaceutical (REPL.SI), another Singapore-listed Chinese pharmaceutical company, jumped as much as 21% after it announced its plan to delist from the stock exchange.   “Pharmaceuticals is one of those sunrise sectors and if you look at the valuations, these two companies look very attractive when compared to their regional rivals,” said a local analyst.

 

CIMB::

C&O Pharm Tech announced that Sumitomo Corp has entered into a sale and purchase agreement with Leo Star Development (helmed by Executive Chairman, Mr Gao) for a 29% stake in C&O for S$96.2m, representing S$0.50 per share (representing a 3% premium over last trade price of S$0.485). Upon completion of the acquisition, Mr. Gao and Leo Star together will own 29.2% stake in the company, while Sumitomo will become the Group’s second largest shareholder with 29% stake.

Maintain Buy, TP S$0.66. 

/cimb/

/i read i posted fyi/

 

 

bingo with strategic foreign partner in the company

 

have mentioned this in my previous link. waiting for the news of the foreign players to be released end of oct. its delayed for a month but if its good news its worth the wait for this gem. have been monitoring this stock for long time. hopefully its some news with the foreign players. it will be worth much more than the target price here. the latest medicine they r manufacturing now worth a billion yuan, yes, just on this. they have hundreds of medicines and extensive distributors, selling their products into clinics and hospitals throughtout the whole china.

 

load up before you are left out. 

 

from CIMB:::

C&O Pharm Tech asked for trading halt last evening.

We mentioned before that we understand the group is in active discussion for collaboration opportunities with foreign pharmaceutical names, with an aim to enrich its product portfolio by introducing more premium products to the PRC market, and to uplift C&O to a new platform.

Maintain BUY and with target price at S$0.66

/FYI. 

 

any reason why delisting? 

chinton86      ( Date: 30-Nov-2010 13:24) Posted: A possible delisting....